Amsterdam UMC Stichting — Sponsor Intelligence | 99 EU Trials

Filter these 99 trials by condition, phase, country and more.

Open in Search →

99 Registered trials

56 Recruiting

23 Completed trials

10 Countries active

125 Unique IMPs

100% Results reported

Phase III

Phase II

Phase IV

Phase III: 18 Phase II/III: 4 Phase II: 24 Phase I/II: 9 Phase III/IV: 6 Phase IV: 35 Phase I (Other): 2 Phase I (FiH): 1

Oversight events:

1 temporary halt across 1 trial

View oversight register →

100%

23 of 23 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Fibrodysplasia ossificans progressiva 2 Colitis ulcerative 2 Crohn's disease 1 Heritable pulmonary arterial hypertension 1 Menopause 1 Pitt-Hopkins syndrome 1 Psoriasis 1 Vulval cancer stage I 1 Adrenocortical carcinoma 1 Bush-Francis catatonia rating scale 1 Complicated appendicitis 1 Lupus nephritis 1

Top IMPs

IPILIMUMAB 3 [18F]FLUORO-PEG-FOLATE 2 CAPECITABINE 2 DURVALUMAB 2 ESTRADIOL 2 FLORTAUCIPIR (18F) 2 FLUDEOXYGLUCOSE (18F) 2 HYDROCORTISONE 2 METHOTREXATE 2 PEMBROLIZUMAB 2 PROGESTERONE, MICRONISED 2 SODIUM CHLORIDE 2

All trials — page 2

99 total

A multi-centred, partially randomised, patient-preference trial of radical surgery versus adjuvant chemoradiotherapy after local excision fo… Recruiting

2024-517410-15-01 Phase III 2 countries CAPECITABINE
SILVER-study Recruiting

2024-517502-28-01 Phase IV 1 country VEDOLIZUMAB
COLLISION RELAPSE trial Recurrent colorectal liver metastases: repeat local treatment +/- neoadjuvant systemic therapy, a phase III prospect… Recruiting

2024-515341-41-01 Phase III/IV 1 country CALCIUM FOLINATE PENTAHYDRATE; CAPECITABINE; FLUOROURACIL; IRINOTECAN HYDROCHLOR…
Synaptic density and tau pathology in Alzheimer’s disease Recruiting

2024-517636-22-00 Phase II 1 country (4R)-4-(3-(18F)FLUORANYL-5-FLUOROPHENYL)-1-[(3-METHYLPYRIDIN-4-YL)METHYL]PYRROLI…
Rituximab and obinutuzumab in SLE Recruiting

2024-518965-85-00 Phase IV 1 country
Belimumab in SLE Recruiting

2024-518966-28-00 Phase IV 1 country BELIMUMAB
EvaluaTion of Clinical and laboratory outcomes of Rivaroxaban in short Bowel syndrome patients dEpending on Long term parenteral nutrition: … Recruiting

2024-519078-38-00 Phase IV 1 country RIVAROXABAN
Sodium-oxybate as a potential new treatment for catatonia in patients with depression, bipolar disorder or a psychotic disorder, a randomize… Recruiting

2024-517805-10-01 Phase III 1 country
Dual-immunotherapy and short-course medium-dose radiotherapy, followed by surgery for tumor microenvironment modification in early-stage NSC… Recruiting

2024-516580-87-00 Phase I/II 1 country DURVALUMAB
ESPRIT study Recruiting

2024-519540-32-00 Phase III/IV 1 country FLUVOXAMINE MALEATE
Macrophage and monocyte presence in lupus nephritis before and during treatment Recruiting

2025-522187-32-01 Phase IV 1 country VOCLOSPORIN
Neoadjuvant gemcitabine and cisplatin in combination with perioperative pembrolizumab versus upfront surgery for patients with primary resec… Recruiting

2024-516898-72-00 Phase II/III 1 country
The PEARL trial: Prevention of hepatic Encephalopathy by administration of Rifaximin and Lactulose in patients with liver cirrhosis undergoi… Recruiting

2024-512040-28-01 Phase IV 2 countries LACTULOSE; RIFAXIMIN
The effect of transdermal 17-β-estradiol/progesterone supplementation on glucose regulation in peri- and postmenopausal women with type 1 an… Recruiting

2025-523214-83-00 Phase IV 1 country ESTRADIOL; PROGESTERONE, MICRONISED
Sonlicromanol in post-COVID: A randomized, double-blind, placebo-controlled, phase II trial Recruiting

2025-521866-92-01 Phase II 1 country SONLICROMANOL HYDROCHLORIDE
Guanabenz in VWM: extension study Recruiting

2024-518834-95-02 Phase I/II 1 country GUANABENZ ACETATE
PROMOTE Recruiting

2024-520351-24-00 Phase IV 1 country PRASUGREL
TransBronchial Needle injection of Tremelimumab in early-stage NSCLC patients (TALENT) Recruiting

2024-511878-67-00 Phase I/II 1 country SODIUM CHLORIDE; TREMELIMUMAB
Sleeping through Menopause Recruiting

2024-512071-12-00 Phase IV 1 country ESTRADIOL; PROGESTERONE, MICRONISED
STOP-RIO: A randomized controlled non-inferiority trial to test the safety of discontinuation of riociguat after balloon pulmonary angioplas… Recruiting

2024-519225-38-00 Phase III/IV 1 country RIOCIGUAT
Preventing postoperative complications in patients undergoing high-risk pancreatoduodenectomy with a bundle approach including hydrocortison… Recruiting

2024-519667-18-00 Phase IV 7 countries HYDROCORTISONE; OCTREOTIDE ACETATE
Safety and Preliminary Clinical Efficacy of MT-302 with CapOx based regimens in metastatic esophagogastric cancer (SPaCE-MT) Recruiting

2024-520213-45-00 Phase I/II 1 country
Continuing ovulation induction with letrozole versus switching to gonadotropins in women with polycystic ovary syndrome (MOVIN-II study) Recruiting

2024-519354-36-00 Phase IV 1 country
SIMBA Recruiting

2024-514740-82-00 Phase IV 1 country VEDOLIZUMAB

Showing 25–48 of 99 trials

← All sponsors A–Z